Mereo BioPharma Group Plc (MREO)
0.2738
0.00 (0.00%)
USD |
NASDAQ |
Nov 20, 10:10
Mereo BioPharma Group Cash from Operations (Quarterly) : -4.048M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -4.048M |
| June 30, 2026 | -6.048M |
| March 31, 2026 | -4.305M |
| December 31, 2025 | -7.670M |
| September 30, 2025 | -7.256M |
| June 30, 2025 | -7.756M |
| Date | Value |
|---|---|
| March 31, 2025 | -8.361M |
| December 31, 2024 | -9.329M |
| September 30, 2024 | -7.619M |
| June 30, 2024 | -7.914M |
| March 31, 2024 | -7.986M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -2.037M |
| BioNTech SE | -148.25M |
| Silence Therapeutics Plc | -12.79M |
| Autolus Therapeutics Plc | -18.51M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -22.37M |
| Free Cash Flow Per Share (Quarterly) | -0.0252 |
| Free Cash Flow to Equity (Quarterly) | -3.595M |
| Free Cash Flow to Firm (Quarterly) | -4.048M |
| Free Cash Flow Yield | -51.16% |